Proteogenomic Insights Into Glioblastoma Evolution: Neuronal Reprogramming and Therapeutic Vulnerabilities

Keyphrases

• Proteogenomics 100%
• Therapeutic Vulnerabilities 100%
• Glioblastoma Evolution 100%
• Neuronal Reprogramming 100%
• Tumor 50%
• Proteomic Analysis 50%
• In Cancer 50%
• Vulnerability 50%
• Proteomics 50%
• Recurrence Rate 50%
• Cancer Cells 50%
• Malignancy 50%
• Niche Adaptation 50%
• Rational Design 50%
• Kinase Activation 50%
• RAF Kinase 50%
• Tumor Treatment 50%
• Patient-specific 50%
• Tumor Invasion 50%
• Targeted Therapy 50%
• Glioblastoma 50%
• Chemotherapy Resistance 50%
• RNA Sequencing (RNA-seq) 50%
• Recurrent Tumor 50%
• Integrative Approach 50%
• Treatment Resistance 50%
• Biomarker Discovery 50%
• Signaling Kinases 50%
• Phosphoproteomics 50%
• Whole Exome Sequencing 50%
• Clonal Evolution 50%
• Tumor Evolution 50%
• Invasion Resistance 50%
• Recurrent Glioblastoma 50%
• Phenotypic Transition 50%
• Treatment-resistant 50%
• Standard-of-care Therapy 50%
• Functional Landscape 50%
• Planar Cell Polarity (PCP) Signaling 50%
• Tumor Plasticity 50%
• Synaptic Crosstalk 50%
• Neuronal Niche 50%
• Recurrent GBM 50%
• Biological Program 50%

Biochemistry, Genetics and Molecular Biology

• Reprogramming 100%
• Proteogenomics 100%
• Kinase 33%
• Phosphotransferase 33%
• Cancer Cell 33%
• RNA Sequence 33%
• Biomarker Discovery 33%
• Phosphoproteomics 33%
• Exome Sequencing 33%
• Clonal Evolution 33%
• Cell Polarity 33%
• Proteomics 33%
• Targeted Therapy 33%
• Niche Adaptation 33%